Ponatinib: Harnessing the elixir potential

Bibliographic Details
Main Author: Vishal Jayakar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Cancer Research, Statistics, and Treatment
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=138;epage=139;aulast=Jayakar
_version_ 1819012008494759936
author Vishal Jayakar
author_facet Vishal Jayakar
author_sort Vishal Jayakar
collection DOAJ
first_indexed 2024-12-21T01:37:13Z
format Article
id doaj.art-5e721553801e46628e7aeac80e2bc65c
institution Directory Open Access Journal
issn 2590-3233
2590-3225
language English
last_indexed 2024-12-21T01:37:13Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Cancer Research, Statistics, and Treatment
spelling doaj.art-5e721553801e46628e7aeac80e2bc65c2022-12-21T19:20:15ZengWolters Kluwer Medknow PublicationsCancer Research, Statistics, and Treatment2590-32332590-32252020-01-013113813910.4103/CRST.CRST_20_20Ponatinib: Harnessing the elixir potentialVishal Jayakarhttp://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=138;epage=139;aulast=Jayakar
spellingShingle Vishal Jayakar
Ponatinib: Harnessing the elixir potential
Cancer Research, Statistics, and Treatment
title Ponatinib: Harnessing the elixir potential
title_full Ponatinib: Harnessing the elixir potential
title_fullStr Ponatinib: Harnessing the elixir potential
title_full_unstemmed Ponatinib: Harnessing the elixir potential
title_short Ponatinib: Harnessing the elixir potential
title_sort ponatinib harnessing the elixir potential
url http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=138;epage=139;aulast=Jayakar
work_keys_str_mv AT vishaljayakar ponatinibharnessingtheelixirpotential